The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.486
https://www.valueinhealthjournal.com/article/S1098-3015(18)32843-2/fulltext
Title :
The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32843-2&doi=10.1016/j.jval.2018.07.486
First page :
Section Title :
Open access? :
No
Section Order :
430